Populationsfarmakokinetisk analyser viste, at der var en tendens mod højere ustekinumab- clearance hos patienter, der var testet positive for antistoffer mod ustekinumab.
Population pharmacokinetic analysis showed that there was a trend towards a higher clearance of ustekinumab in patients who tested positive for antibodies to ustekinumab.